$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Effect of Training Intensity on Nonalcoholic Fatty Liver Disease 원문보기

Medicine and science in sports and exercise, v.47 no.8, 2015년, pp.1624 - 1634  

CHO, JINKYUNG (1College of Sport Science, Sungkyunkwan University, Suwon, REPUBLIC OF KOREA) ,  KIM, SHINUK (2College of Engineering, Sangmyung University, Cheonan, REPUBLIC OF KOREA) ,  LEE, SHINHO (and 3Division of Humanities and Social Sciences, Pohang University of Science and Technology, Pohang, REPUBLIC OF KOREA) ,  KANG, HYUNSIK

Abstract

BACKGROUND: Training intensity may play a key role in magnifying the protective effect of physical exercise against nonalcoholic fatty liver disease (NAFLD). PURPOSE: This study aimed to test the hypothesis that vigorous-intensity and interval training is as effective as moderate-intensity and continuous exercise training on NAFLD in high-fat diet (HFD)-induced obese mice. METHODS: C57BL/6 mice (N = 40) were fed a standard-chow diet (n = 10) or HFD (n = 30) for 16 wk. After the initial 8-wk dietary treatments, HFD mice were further divided into HFD only (n = 10), HFD plus vigorous-intensity and interval treadmill running (VIT) (n = 10), and HFD plus moderate-intensity and continuous treadmill running (MIT) (n = 10) for the remaining 8-wk period. RESULTS: Chronic exposure to HFD resulted in hepatic steatosis in conjunction with an obese and impaired glucose tolerance condition characterized by dyslipidemia, hyperinsulinemia elevated markers for the liver damage, and hypoadiponectinemia. Although VIT and MIT alleviated the NAFLD conditions, the former was more effective at alleviating hepatic steatosis than the latter. The intensity-dependent benefit of exercise training against hepatic steatosis was associated with greater activation of VIT on hepatic AMP-mediated protein kinase in conjunction with greater suppressive effect of VIT on hypoadiponectinemia, downregulation of the Adiponectin receptor 2 signaling pathway, and upregulation of the NF-&kgr;B signaling pathway in the liver. CONCLUSIONS: The current findings suggest that VIT is an alternative way of exercise training to combat hepatic steatosis associated with an obese and impaired glucose tolerance phenotype.

참고문헌 (51)

  1. Gastroenterology 123 5 1702 2002 10.1053/gast.2002.36569 American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease. 

  2. Am J Physiol Gastrointest Liver Physiol Baumgardner 294 1 G27 2008 10.1152/ajpgi.00296.2007 A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet. 

  3. Am J Physiol Endocrinol Metab Bradley 295 3 E586 2008 10.1152/ajpendo.00309.2007 Voluntary exercise improves insulin sensitivity and adipose tissue inflammation in diet-induced obese mice. 

  4. Rev Esp Enferm Dig Cayon 100 4 212 2008 Gene expression in obese patients with non-alcoholic steatohepatitis in Spanish. 

  5. Diabetes Chen 52 9 2205 2003 10.2337/diabetes.52.9.2205 Effect of exercise intensity on skeletal muscle AMPK signaling in humans. 

  6. Liver Int Deng 27 5 708 2007 10.1111/j.1478-3231.2007.01497.x The expression of SIRT1 in nonalcoholic fatty liver disease induced by high-fat diet in rats. 

  7. Cell Metab Finck 4 3 199 2006 10.1016/j.cmet.2006.08.005 Lipin 1 is an inducible amplifier of the hepatic PGC-1alphaPPARalpha regulatory pathway. 

  8. J Biol Chem Folch 226 1 497 1957 10.1016/S0021-9258(18)64849-5 A simple method for the isolation and purification of total lipids from animal tissues. 

  9. Hepatology Handa 60 1 133 2014 10.1002/hep.26946 Reduced adiponectin signaling due to weight gain results in nonalcoholic steatohepatitis through impaired mitochondrial biogenesis. 

  10. Cardiovasc Res Haram 81 4 723 2009 10.1093/cvr/cvn332 Aerobic interval training vs. continuous moderate exercise in the metabolic syndrome of rats artificially selected for low aerobic capacity. 

  11. Gut Harrison 56 12 1760 2007 10.1136/gut.2006.112094 Benefits of lifestyle modification in NAFLD. 

  12. J Sports Med Phys Fitness He 48 2 259 2008 The effects of swimming exercise on high-fat-diet-induced steatohepatitis. 

  13. Nat Commun Herranz 1 3 2010 10.1038/ncomms1001 Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer. 

  14. Exp Clin Endocrinol Diabetes Huang 115 7 417 2007 10.1055/s-2007-981660 The regulation of adiponectin receptors expression by acute exercise in mice. 

  15. Muscle Nerve Hunter 24 5 654 2001 10.1002/mus.1051 Muscle metabolic economy is inversely related to exercise intensity and type II myofiber distribution. 

  16. Cancer Res Jiang 68 13 5492 2008 10.1158/0008-5472.CAN-07-6721 Dietary energy restriction modulates the activity of AMP-activated protein kinase, Akt, and mammalian target of rapamycin in mammary carcinomas, mammary gland, and liver. 

  17. Endocr Rev Kadowaki 26 3 439 2005 10.1210/er.2005-0005 Adiponectin and adiponectin receptors. 

  18. J Clin Invest Kadowaki 116 7 1784 2006 10.1172/JCI29126 Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. 

  19. Gut Kaser 54 1 117 2005 10.1136/gut.2003.037010 Adiponectin and its receptors in non-alcoholic steatohepatitis. 

  20. Am J Gastroenterol Kistler 106 3 460 2011 10.1038/ajg.2010.488 Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. 

  21. Hepatology Krasnoff 47 4 1158 2008 10.1002/hep.22137 Health-related fitness and physical activity in patients with nonalcoholic fatty liver disease. 

  22. Gastroenterology Li 146 2 539 2014 10.1053/j.gastro.2013.10.059 Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21. 

  23. Hepatology Li 37 2 343 2003 10.1053/jhep.2003.50048 Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. 

  24. Med Sci Sports Exerc Linden 47 3 556 2015 10.1249/MSS.0000000000000430 Treating NAFLD in OLETF rats with vigorous-intensity interval exercise training. 

  25. Metabolism Matsunami 60 6 805 2011 10.1016/j.metabol.2010.07.032 Regulation of synthesis and oxidation of fatty acids by adiponectin receptors (AdipoR1R2) and insulin receptor substrate isoforms (IRS-1-2) of the liver in a nonalcoholic steatohepatitis animal model. 

  26. Antioxid Redox Signal Morris 15 2 485 2011 10.1089/ars.2010.3795 Mitochondria and redox signaling in steatohepatitis. 

  27. Am J Physiol Endocrinol Metab Musi 280 5 E677 2001 10.1152/ajpendo.2001.280.5.E677 AMP-activated protein kinase activity and glucose uptake in rat skeletal muscle. 

  28. World J Gastroenterol Nagarajan 18 11 1141 2012 10.3748/wjg.v18.i11.1141 Genetically modified mouse models for the study of nonalcoholic fatty liver disease. 

  29. Med Sci Sports Exerc Oh 45 12 2214 2013 10.1249/MSS.0b013e31829afc33 Exercise reduces inflammation and oxidative stress in obesity-related liver diseases. 

  30. J Biol Chem Park 277 36 32571 2002 10.1074/jbc.M201692200 Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise. 

  31. Int J Obes (Lond) Rametta 37 7 986 2013 10.1038/ijo.2012.181 Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects. 

  32. Biochem J Richter 418 2 261 2009 10.1042/BJ20082055 AMPK and the biochemistry of exercise: implications for human health and disease. 

  33. Nat Rev Gastroenterol Hepatol Rodriguez 9 12 726 2012 10.1038/nrgastro.2012.200 Physical activity: an essential component of lifestyle modification in NAFLD. 

  34. Metabolism Shimizu 56 11 1478 2007 10.1016/j.metabol.2007.06.013 Regulation of adiponectin receptor expression in human liver and a hepatocyte cell line. 

  35. Drug Discov Today Silva 15 17-18 781 2010 10.1016/j.drudis.2010.07.001 Role of sirtuin 1 in metabolic regulation. 

  36. Adv Ther Stein 26 10 893 2009 10.1007/s12325-009-0072-z Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: current status. 

  37. Am J Physiol Endocrinol Metab Stephens 282 3 E688 2002 10.1152/ajpendo.00101.2001 Progressive increase in human skeletal muscle AMPKalpha2 activity and ACC phosphorylation during exercise. 

  38. Metabolism Takekoshi 55 8 1122 2006 10.1016/j.metabol.2006.04.007 Long-term exercise stimulates adenosine monophosphate-activated protein kinase activity and subunit expression in rat visceral adipose tissue and liver. 

  39. Circulation Tjonna 118 4 346 2008 10.1161/CIRCULATIONAHA.108.772822 Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study. 

  40. Hepatology Tomita 48 2 458 2008 10.1002/hep.22365 Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice. 

  41. Gut Tomita 55 3 415 2006 10.1136/gut.2005.071118 Tumor necrosis factor alpha signaling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice. 

  42. Metabolism Tremblay 43 7 814 1994 10.1016/0026-0495(94)90259-3 Impact of exercise intensity on body fatness and skeletal muscle metabolism. 

  43. J Biol Chem Tsuchida 279 29 30817 2004 10.1074/jbc.M402367200 InsulinFoxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. 

  44. Med Sci Sports Exerc Van Der Heijden 42 11 1973 2010 10.1249/MSS.0b013e3181df16d9 Strength exercise improves muscle mass and hepatic insulin sensitivity in obese youth. 

  45. Am J Physiol Endocrinol Metab Wada 305 11 E1415 2013 10.1152/ajpendo.00419.2013 Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose diet. 

  46. Am J Med Wang 115 7 554 2003 10.1016/S0002-9343(03)00449-2 Is weight reduction an effective therapy for nonalcoholic fatty liver A systematic review. 

  47. Arch Biochem Biophys Witters 308 2 413 1994 10.1006/abbi.1994.1058 Hepatic 5-AMP-activated protein kinase: zonal distribution and relationship to acetyl-CoA carboxylase activity in varying nutritional states. 

  48. Biochem Biophys Res Commun Xu 404 4 1060 2011 10.1016/j.bbrc.2010.12.110 Adiponectin inhibits lymphotoxin- receptor-mediated NF-B signaling in human umbilical vein endothelial cells. 

  49. Nat Med Yamauchi 13 3 332 2007 10.1038/nm1557 Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. 

  50. J Exerc Sci Fit Zhang 7 1 18 2009 10.1016/S1728-869X(09)60003-4 Effects of 12 weeks of exercise on hepatic TNF- and PPAR in an animal model of high-fat diet-induced nonalcoholic steatohepatitis. 

  51. J Physiol Zoladz 488 Pt 1 211 1995 10.1113/jphysiol.1995.sp020959 Non-linear relationship between O2 uptake and power output at high intensities of exercise in humans. 

LOADING...
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로